• Michigan cancer drug donation program looks to cut waste, help those in need

    Published On: October 26, 2023Categories: Member News

    A new statewide program will allow cancer patients unable to afford or access cancer drugs to obtain medications that might otherwise go to waste. Under the program, people can donate no-longer-needed cancer drugs or supplies to a repository, allowing them to be repurposed for patients in need. The Ann Arbor-based YesRx repository establishes a network of pharmacists that can accept cancer drug donations from individuals, pharmacies, manufacturers and distributors, then re-prescribe them to cancer patients requiring the same dosage. Donors can turn in unused, unopened cancer medications and supplies, such as anti-nausea medicine, to doctors, pharmacists and other providers participating in the repository system. The medications must have at least six months left before their expiration. “The idea is to get [...]

    Read More
  • APhA Stands with Pharmacists in Ensuring a Safe Patient Environment

    Published On: September 27, 2023Categories: Member News

    In a statement issued Tuesday following the recent pharmacy store closures in the Kansas City area, the American Pharmacists Association (APhA) said it stands with pharmacists in ensuring a safe patient care environment. "As pharmacists, we have a professional obligation through our Oath to consider the welfare of humanity and the relief of suffering as our primary concerns," APhA stated "We further commit to advocating for changes that improve patient care. Pharmacists who find themselves in situations where the welfare of others is in question should always pause, evaluate the situation, and take the steps necessary to ensure safe, optimal patient care. This is irrespective of the setting of care." APhA noted that in 2021 it convened a summit of [...]

    Read More
  • Community Pharmacists Cheer Class Action Lawsuit Against PBMs to Recoup DIR Fees

    Published On: September 27, 2023Categories: Member News

    The National Community Pharmacists Association loudly applauded a class action lawsuit filed against vertically consolidated CVS Health, Caremark and Aetna that aims to recoup millions of dollars for independent pharmacies in what the lawyers say are wrongful back-end penalties for Medicare Part D prescriptions, otherwise known as pharmacy direct and indirect remuneration fees. “It’s payback time,” said NCPA CEO B. Douglas Hoey. “Finally, community pharmacies have a chance to recover DIR fees that were unfairly taken. PBMs have been gaming the system for a long time and it’s time to turn the tables.” The lawsuit, announced today by the law firms Berger Montague PC and Cohen & Gresser LLP, claims that Caremark – the largest pharmacy benefit manager in the country and [...]

    Read More
  • CDC Recommends New COVID-19 Vaccines for all Americans

    Published On: September 13, 2023Categories: Member News

    The Centers for Disease Control (CDC) and its advisors recommended Tuesday that everyone age 6 months and older receive at least one dose of updated COVID-19 vaccines. The Food and Drug Administration (FDA) approved the updated vaccines developed by Moderna and Pfizer-BioNTech on Monday. Updated COVID-19 vaccines are expected to be available at major pharmacies later this week. In the coming months, the guidelines are expected to include vaccines by Novavax and any others authorized by FDA; the Novavax vaccine may serve as a good alternative for individuals who cannot receive mRNA vaccines like those made by Moderna and Pfizer. According to information submitted to CDC's advisory panel, Moderna, Pfizer and Novavax intend to charge $120 to $130 per dose [...]

    Read More
  • FDA Green Lights Updated MNRA COVID Vaccines

    Published On: September 11, 2023Categories: Uncategorized

    The U.S. Food and Drug Administration today approved for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious consequences of COVID-19, including hospitalization and death. The actions relate to updated mRNA vaccines for 2023-2024 manufactured by ModernaTX Inc. and Pfizer Inc. These vaccines have been updated to include a monovalent (single) component that corresponds to the Omicron variant XBB.1.5. The updated mRNA vaccines are each approved for individuals 12 years of age and older and are authorized under emergency use for individuals 6 months through 11 years of age. As part of today’s actions, the bivalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the [...]

    Read More